Savant Capital’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $275K | Sell |
2,174
-99
| -4% | -$12.5K | ﹤0.01% | 1441 |
|
|
2025
Q1 | $291K | Sell |
2,273
-101
| -4% | -$12.9K | ﹤0.01% | 1238 |
|
|
2024
Q4 | $314K | Sell |
2,374
-175
| -7% | -$23.1K | ﹤0.01% | 1088 |
|
|
2024
Q3 | $371K | Sell |
2,549
-315
| -11% | -$45.9K | ﹤0.01% | 1000 |
|
|
2024
Q2 | $393K | Sell |
2,864
-259
| -8% | -$35.6K | ﹤0.01% | 880 |
|
|
2024
Q1 | $428K | Sell |
3,123
-584
| -16% | -$80.1K | ﹤0.01% | 784 |
|
|
2023
Q4 | $504K | Sell |
3,707
-674
| -15% | -$91.6K | 0.01% | 561 |
|
|
2023
Q3 | $536K | Buy |
4,381
+319
| +8% | +$39K | 0.01% | 509 |
|
|
2023
Q2 | $516K | Buy |
4,062
+114
| +3% | +$14.5K | 0.01% | 499 |
|
|
2023
Q1 | $510K | Buy |
+3,948
| New | +$510K | 0.01% | 459 |
|
|
2018
Q4 | – | Sell |
-1,686
| Closed | -$206K | – | 278 |
|
|
2018
Q3 | $206K | Buy |
+1,686
| New | +$206K | 0.04% | 285 |
|